Report Publication Announcement • Jul 25, 2024
Report Publication Announcement
Open in ViewerOpens in native device viewer
Paris, July 25, 2024. Sanofi announces that its half-year financial report for the period ending June 30, 2024 is now available and has been filed with the French market regulator Autorité des marchés financiers (AMF) and submitted to the U.S. Securities and Exchange Commission (SEC) under form 6-K.
This document may be found on the company's corporate website: www.sanofi.com and downloaded from the "Investors" page, under the heading "Regulated Information in France".
We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people's lives. Our team, across the world, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions.
Sanofi is listed on EURONEXT: SAN and NASDAQ: SNY
Sandrine Guendoul | + 33 6 25 09 14 25 | [email protected] Léo Le Bourhis | + 33 6 75 06 43 81 | [email protected] Victor Rouault | + 33 6 70 93 71 40 | [email protected]
Thomas Kudsk Larsen |+ 44 7545 513 693 | [email protected] Alizé Kaisserian | + 33 6 47 04 12 11 | [email protected] Arnaud Delépine | + 33 6 73 69 36 93 | [email protected] Felix Lauscher | + 1 908 612 7239 | [email protected] Keita Browne | + 1 781 249 1766 | [email protected] Nathalie Pham | + 33 7 85 93 30 17 | [email protected] Tarik Elgoutni | + 1 617 710 3587 | [email protected] Thibaud Châtelet | + 33 6 80 80 89 90 | [email protected]
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.